Dulbecco’s modified Eagle medium (DMEM, 41965062) and fetal bovine serum (FBS, 10100-147) from Gibco (Grand Island, NY, USA); FuGENE® HD (E2311) and Dual-Luciferase® Reporter Assay System from Promega (Madison, WI, USA); Leukemia Inhibit Factor from mouse (mLIF, L5158), Fibroblast Growth Factor-Basic human (bFGF, F0291), Stem Cell Human (SCF, S7901); TSA from Sigma (St. Louis, MO, USA); PARIS™ from Ambion (Austin, TX, USA); retinoic acid (R2625) from Sigma.
Anti ddx4 cvh ab13840
Anti-DDX4/Cvh (ab13840) is a primary antibody that recognizes the DDX4/Cvh protein. DDX4/Cvh is a member of the DEAD box protein family and is involved in spermatogenesis and oogenesis.
Lab products found in correlation
2 protocols using anti ddx4 cvh ab13840
Comprehensive Pluripotency Marker Analysis
Dulbecco’s modified Eagle medium (DMEM, 41965062) and fetal bovine serum (FBS, 10100-147) from Gibco (Grand Island, NY, USA); FuGENE® HD (E2311) and Dual-Luciferase® Reporter Assay System from Promega (Madison, WI, USA); Leukemia Inhibit Factor from mouse (mLIF, L5158), Fibroblast Growth Factor-Basic human (bFGF, F0291), Stem Cell Human (SCF, S7901); TSA from Sigma (St. Louis, MO, USA); PARIS™ from Ambion (Austin, TX, USA); retinoic acid (R2625) from Sigma.
Pluripotency Induction and Maintenance
Recombinant Human Bone Morphogenetic Protein-4 (BMP4, cyt-361) is from PROSPEC Dulbecco's modi ed Eagle medium (DMEM. 41965062) and Fetal bovine serum (FBS. 10100-147) from Gibco; FuGENE® HD (E2311) and Dual-Luciferase® Reporter Assay System from Promega; Leukemia Inhibit Factor from mouse (mLIF L5158), Fibroblast Growth Factor-Basic human (bFGF, F0291), Stem Cell Human (SCF. S7901); 5-aza-2'-deoxycytidine and TSA from Sigma; Pierce RNA 3' end desthiobiotinylation kit from Thermo; RIP-Assay Kit (RN1001) from MBL; PARIS™ from Ambion; PAS / Glycogen Stain kit (D004-1-2) from Nanjing Jiancheng Bioengineering Institute.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!